| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.0087 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0013 | 1 |